patients with carcinoma of the lung a 14 year experience
play

Clinical Presentation and Management of Patients with Carcinoma of the Lung: A 14-Year Experience Marvin M. Kirsh, MD, Jeanne Tashian, and Herbert Sloan, MD Ann A rbor, M ichigan C a r c i n o m a o f t h e l u n g h a s b e e n s t e a d

0 downloads 1 Views 3,21 MB Size Report
  1. Clinical Presentation and Management of Patients with Carcinoma of the Lung: A 14-Year Experience Marvin M. Kirsh, MD, Jeanne Tashian, and Herbert Sloan, MD Ann A rbor, M ichigan C a r c i n o m a o f t h e l u n g h a s b e e n s t e a d i l y i n c r e a s i n g s i n c e W o r l d W a r I I , a n d t h e f a m i l y p h y s i c i a n c a n n o w e x p e c t t o s e e a g r e a t e r i n c i d e n c e o f t h e d i s e a s e i n w o m e n a n d p e r s o n s u n d e r a g e 5 0 y e a r s . T h e c l i n i c a l m a n i f e s t a t i o n s o f c a r c i n o m a o f t h e l u n g a r e d e ­ s c r i b e d , b a s e d o n a 1 4 - y e a r e x p e r i e n c e a t t h e U n i v e r s i t y o f M i c h i g a n . D i a g n o s t i c p r o c e d u r e s a r e o u t l i n e d . T h e p r e f e r r e d t r e a t m e n t f o r c a r c i n o m a o f t h e l u n g i s p u l m o n a r y r e s e c t i o n , c o m b i n e d , i n a p p r o p r i a t e s i t u a t i o n s , w i t h m e d i a s t i n a l l y m p h n o d e i r r a d i a t i o n . S u r v i v a l i s d e p e n d e n t t o s o m e d e g r e e o n t h e t u m o r c e l l t y p e a s w e l l a s t h e e x t e n t o f m e t a s t a s i s . A n e w i m m u n o t h e r a p e u t i c a d j u n c t t o r e s e c t i o n a n d i r r a d i a ­ t i o n i s b e i n g d e v e l o p e d . F i v e t o t e n - y e a r s u r v i v o r s o f r e s e c ­ t i o n s f o r l u n g c a n c e r a n d n o r m a l p e r s o n s s e r v e a s l y m p h o c y t e d o n o r s . T r a n s f e r f a c t o r i s e x t r a c t e d f r o m t h e s e l y m p h o c y t e s a n d i n j e c t e d i n t o s e l e c t e d p a t i e n t s w h o h a v e r e c e n t l y h a d r e ­ s e c t i o n s f o r l u n g c a n c e r . I t i s t o o s o o n t o e v a l u a t e t h e r e s u l t s o f t h i s e x p e r i m e n t , b u t i t i s h o p e d t h a t i m m u n o t h e r a p y u s i n g t r a n s f e r f a c t o r w i l l b e o f h e l p t o p a t i e n t s w i t h c a r c i n o m a o f t h e l u n g . D u r i n g t h e p a s t 6 0 y e a r s t h e r e h a s b e e n a m a r k e d r i s e h a s b e e n a s s o c i a t e d p r i m a r i l y w i t h a n m a r k e d i n c r e a s e i n t h e i n c i d e n c e o f c a r c i n o m a o f i n c r e a s e i n c i g a r e t t e s m o k i n g , b u t a l s o w i t h e n ­ th e l u n g , w i t h a n e s t i m a t e d 8 5 , 0 0 0 t o 9 2 , 0 0 0 p e r ­ v i r o n m e n t a l f a c t o r s s u c h a s u r b a n a i r p o l l u t i o n a n d s o n s i n t h e U n i t e d S t a t e s d y i n g o f t h e d i s e a s e e a c h e x p o s u r e t o c e r t a i n i n d u s t r i a l a g e n t s s u c h a s a s ­ y e a r . 1 W i t h t h e t o t a l n u m b e r o f n e w c a s e s e x p e c t e d b e s t o s , c h r o m i u m , a n d n i c k e l . A b o u t 9 0 p e r c e n t o f to b e a b o u t 1 0 2 , 0 0 0 i n 1 9 7 8 , t h e f a m i l y p h y s i c i a n a l l l u n g c a n c e r i s d i r e c t l y a t t r i b u t a b l e t o h e a v y c a n w e l l e x p e c t t o e n c o u n t e r p a t i e n t s w i t h c a r ­ c i g a r e t t e s m o k i n g , i e , t w o t o t h r e e p a c k s a d a y f o r c i n o m a o f t h e l u n g i n t h e c o u r s e o f t h e y e a r . T h i s 2 0 o r m o r e y e a r s . T h i r t y y e a r s a g o t h e m a l e - f e m a l e i n c i d e n c e o f l u n g c a n c e r w a s a l m o s t 5 : 1 , b u t w i t h t h e i n c r e a s e i n s m o k i n g a m o n g w o m e n w h i c h b e g a n d u r i n g From the Departm ent of Surgery, Section of Thoracic Surgery, The U niversity of M ichigan Medical Center, Ann W o r l d W a r I I , t h i s r a t i o h a s b e e n c l o s i n g . O f t h e Arbor, Michigan. Requests for reprints should be ad­ 9 2 , 0 0 0 d e a t h s f r o m l u n g c a n c e r p r e d i c t e d f o r 1 9 7 8 , dressed to Dr. M arvin M. Kirsh, C7079 Out-Patient Building, University Hospital, Ann Arbor, Ml 48109. t h e A m e r i c a n C a n c e r S o c i e t y e s t i m a t e s 7 0 , 5 0 0 w i l l 0094-3509/79/061127-05$01.25 0 1979 Appleton-Century-Crofts TH E j o u r n a l o f f a m i l y 1127 PRACTICE, VOL. 8, NO. 6: 1127-1131, 1979

Recommend Documents


initial results from a phase ii study tacti 002 in
Initial results from a Phase II study

Initial results from a Phase II study (TACTI-002) in metastatic non- small

60
60% 78% H&N 705,781 18M 60%

RECEIVING RTx NUMBER OF PATIENTS 83% Breast cancer 2,088,849 76% Lung

first line systemic therapy for patients with
First-Line Systemic Therapy for

First-Line Systemic Therapy for Patients with Unresectable Hepatocellular

unilateral radiotherapy in node positive
Unilateral Radiotherapy in Node

Unilateral Radiotherapy in Node Positive Patients with Lateralized Tonsillar

navigating patients through lung cancer treatment
Navigating patients through lung

Navigating patients through lung cancer treatment Kirsten Mooney -Thoracic

small cell lung carcinoma
SMALL CELL LUNG CARCINOMA Sthenjiswa

SMALL CELL LUNG CARCINOMA Sthenjiswa Mhlongo Consultant: Prof A Sherriff

lung cancer 5 year update
Lung Cancer:5 Year Update Elizabeth

RTOG 0214: A Phase III Comparison of Prophylactic Cranial Irradiation versus

neoadjuvant systemic therapy in metastatic renal cell
Neoadjuvant Systemic Therapy in

Winship Cancer Institute of Emory University Neoadjuvant Systemic Therapy in

lucy gladman general manager bhrut
Lucy Gladman General Manager BHRUT

Lung Cancer MDT Project BHRUT Lucy Gladman General Manager BHRUT Lung MDT

a rare presentation of adenoid cystic carcinoma of
A rare presentation of Adenoid cystic

Eur J Gen Med 2016;13(3):67-69 DOI: 10. 29333 /ejgm / 1505 Case Report A rare

meritus health systems 1 breast cancer breast cancer is
Meritus Health Systems 1 Breast

BREAST CANCER & LUNG CANCER Meritus Health Systems 1 Breast Cancer

prostate cancer
PROSTATE CANCER Mr. Jawad Islam MBBS,

PROSTATE CANCER Mr. Jawad Islam MBBS, MSc, FRCS(Ed), FEBU, FRCS(Urology)

the costs of cancer
The Costs of Cancer Addressing Patient

Cancer Action Network SM The Costs of Cancer Addressing Patient Costs

changing trends of presentation in colorectal carcinoma
Changing Trends of Presentation in

ORIGINAL ARTICLE Changing Trends of Presentation in Colorectal Carcinoma

cancer primary prevention
Cancer-Primary Prevention Chair: Anne

Meeting 4 Cancer-Primary Prevention Chair: Anne McTiernan Members: Peter

a highly potent and selective ret inhibitor
a Highly Potent and Selective RET

Clinical Activity and Tolerability of BLU-667, a Highly Potent and Selective

jason ali
Jason Ali Specialist Registrar in

Jason Ali Specialist Registrar in Cardiothoracic Surgery, NNUH Director of

activating the
Activating the TG mutant RAS

Activating the TG mutant RAS neoantigen vaccine immune Dr. Erik Digman

cancer of unknown primary
Cancer of Unknown Primary Helen

Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of

achievements poster presentations in 2019
Achievements: Poster Presentations in

Achievements: Poster Presentations in 2019 Leptomeningeal metastasis: A A

considerations in development of pembrolizumab in msi h
CONSIDERATIONS IN DEVELOPMENT OF

CONSIDERATIONS IN DEVELOPMENT OF PEMBROLIZUMAB IN MSI-H CANCERS December 2017

we want to save patients with severe cancer and
We want to save patients with severe

We want to save patients with severe cancer and autoimmune diseases Clinical